Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Bio-Techne Corp at Bank of America Healthcare Conference Transcript

May 11, 2022 / 09:40PM GMT
Release Date Price: €82.5 (+1.23%)
Unidentified Analyst

(technical difficulty)

life science tools and diagnostics team working with Derik De Bruin. And joining us for our next slot is Chuck Kummeth, Chief Executive Officer of Bio-Techne. Format's going to be a fire side chat. Feel free to fire off any questions if you want to jump in.

Questions & Answers

Unidentified Analyst

But just to get the ball rolling, Chuck, since BofA doesn't cover you, maybe you can give us a little bit of introduction, the portfolio, your offerings, how you fit into the life science tools ecosystem?

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Well, we've kind of become a proteomics kind of world lately. I mean a decade ago, it was all about NGS, and all of a sudden lo and behold this proteomics is cool again, a little help in the pandemic but it doesn't hurt. But we're situated position, we think perfectly because of that, we've been around 46 years, and we're the world leader in proteins for research, which is the most fundamental tool

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot